Who is the richest person in the pharmaceutical industry?

Dr. Cyrus Poonawalla: The Richest Name in Global Healthcare

When it comes to wealth in the pharmaceutical world, one name stands above the rest—Dr. Cyrus S. Poonawalla. In 2022, he claimed the top spot on the Hurun Global Healthcare Rich List, marking a defining moment in the industry. As Chairman and Managing Director of the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Poonawalla’s influence extends far beyond balance sheets.

His rise to the pinnacle of pharmaceutical wealth wasn’t overnight. Over decades, he built SII into a global powerhouse, particularly during the pandemic, when the company played a crucial role in supplying affordable vaccines worldwide. The production of Covishield, the Indian-manufactured version of the AstraZeneca vaccine, cemented SII’s reputation—and significantly boosted Poonawalla’s net worth.

What sets him apart isn’t just wealth, but impact. Under his leadership, SII has focused on accessibility, producing life-saving vaccines for diseases like measles, polio, and meningitis at a fraction of the global cost. This blend of business acumen and public health commitment has made him not just the richest, but one of the most influential figures in modern medicine.

Though the May 2026 date in the original note appears to be a forward-looking error—since the Hurun list referenced is from 2022—Poonawalla’s legacy remains current. His story reflects a rare fusion of entrepreneurial success and humanitarian reach, proving that in healthcare, true wealth isn’t just measured in dollars, but in lives protected.